Participants stigmatized an individual who had regained weight after using a GLP-1, rating them less favorably than an individual who had lost weight and maintained it (i.e., higher in negative traits, lower in positive traits, more unhealthy, less willing to affiliate) and less favorably, again, than even an individual who had not attempted weight loss (i.e., lower in positive traits)
Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanism
Experiment and find your pattern
Several other conditions can mimic the appearance of this complex disorder, making an accurate diagnosis essential for effective treatment
10.1007/s10545-017-0085-8 J
doi: 10.1046/j.1365-313X.2003.01679.x 27 BaiXZhangRZengQYangWFangFSunQet al